[ad_1] Fusion Pharmaceuticals Inc.’s stock was up by 5.3% in premarket trading on Wednesday, as…
Tag:
IMGN
-
-
STOCK MARKET
Sanofi suffers major blow as its cutting-edge cancer drug disappoints in Phase III trials
by userby user[ad_1] French pharmaceuticals giant Sanofi SAN, -0.44% on Thursday said it would be halting development…